Med 22 SM-guld och 15 cuptitlar är Malmö FF den mest framgångsrika fotbollsföreningen i Sverige. Glädjen och ambitionen har vi tagit med oss även utanför fotbollsplanen. Vårt samhällsengagemang som vi utför i samarbete med företagspartners, kommuner, regioner och andra föreningar berör tusentals unga tjejer och killar i Sverige varje år. MFF ger människor kraft att växa.

Etac is a world-leading developer of innovative assistive devices and patient handling equipment. Since 1973, we have been committed to improving quality of life for the individual, family members and caregivers. Through our specialised product brands, we offer state-of-the-art solutions for a wide range of daily needs and care settings, for people at all stages of life. Our products are designed to promote the individual’s abilities and support caregivers in their daily work – through high quality, user-friendly functionality, and by delivering great value over time. Our dedication has resulted in numerous awards and great customer satisfaction around the world. With a pioneering spirit and innovative mindset, we continue to create possibilities throughout the day, and throughout the years. Etac - Creating possibilities --------------------------------- Our product brands: - Etac: Wheelchairs, bathroom & daily living aids - R82: Paediatric seating, walking, standing, bathroom & transport assistive devices - Convaid: Paediatric wheelchairs & adaptive strollers - Ki: Adult & paediatric wheelchairs - Axiom: Seating & positioning - Star: Seating & positioning - Molift: Hoists, slings & transfer assistive devices - Immedia: Manual transfer & positioning aids - HoverTech: Air-assisted transfer & positioning devices HoverTech products are developed by HoverTech International, of which Etac is the majority owner. For requests outside of EU, please contact HoverTech International in the US.

At Arjo, we believe that empowering movement within healthcare environments is essential to quality care. Our products and solutions are designed to promote a safe and dignified experience through patient handling, medical beds, personal hygiene, disinfection, diagnostics, and the prevention of pressure injuries and venous thromboembolism. With over 6000 people worldwide and 60 years caring for patients and healthcare professionals, we are committed to driving healthier outcomes for people facing mobility challenges. You can find our privacy policy at https://www.arjo.com/int/about-us/legal/privacy-policy/

CellaVision is an innovative, global medical technology company that develops and sells systems for routine analysis of blood and other body fluids in health care services. The products replace manual laboratory work, and support effective workflows and skills development within and between hospitals. The company has expertise in image analysis, artificial intelligence and automated microscopy. Sales are via global distributors, with support from the parent company in Lund and by the market support organizations in the US, Canada, China, Sweden, Japan, United Arab Emirates, South Korea, Australia, France, Germany, Brazil, Great Britain, Mexico, India, Thailand, Spain, Italy, and Russia. In 2020, sales were SEK 471.4 million. CellaVision's registered office is in Lund, Sweden. The share is listed on the Nasdaq Stockholm, Mid Cap list. Read more at www.cellavision.com

Founded in Denmark in 1987 under the name of Medicult, ORIGIO's innovative approach quickly positioned it as one of the leaders in the global IVF Media market. In 2007 and 2008 the range grew with the addition of high-quality glass pipets from Humagen Fertility Diagnostics, as well as IVF equipment and devices including the STRIPPER from MidAtlantic Diagnostics. The company had now become a true ART player and a new name had to be found. ORIGIO was born.

Gambro AB (including all direct and indirect subsidiaries) is a part of Baxter. For nearly a century, Baxter has remained solely focused on our commitment to saving and sustaining lives of patients, clinicians and providers around the world. We believe every person — regardless of who they are or where they are from — deserves a chance to live a healthy life, free from illness and full of possibility. At the intersection of progress and purpose is where we are redefining what it means to be a global medtech leader. It is where we are relentlessly pursuing healthcare transformation, fueled by our compassion for patients and providers. It is where bold ideas meet the promise for meaningful change in the world around us